Cetera Trust Company’s Boston Scientific BSX Stock Holding History

Cetera Trust Company’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$31.8K	Hold	746	–	–	0.02%	242
2026 Q1	$46.8K	Hold	746	–	–	0.03%	221
2025 Q4	$71.1K	Hold	746	–	–	0.04%	208
2025 Q3	$72.8K	Hold	746	–	–	0.04%	211
2025 Q2	$80.1K	Hold	746	–	–	0.05%	210
2025 Q1	$75.3K	Hold	746	–	–	0.05%	209
2024 Q4	$66.6K	Hold	746	–	–	0.04%	210
2024 Q3	$62.5K	Hold	746	–	–	0.04%	224
2024 Q2	$57.4K	Hold	746	–	–	0.04%	222
2024 Q1	$51.1K	Hold	746	–	–	0.03%	230
2023 Q4	$43.1K	Buy	+746	New	+$39.8K	0.03%	233

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Cetera Trust Company's BSX Position: Q2 2026 in Review

Cetera Trust Company held its Boston Scientific (BSX) position steady in Q2 2026 at 746 shares worth $31.8K. The position accounts for 0.02% of the portfolio, ranked #242.

Cetera Trust Company first reported a position in BSX in Q4 2023 and has held it in 11 quarters since. The position peaked at $80.1K in Q2 2025. 1,481 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Cetera Trust Company held 746 shares of Boston Scientific worth $31.8K as of Q2 2026.
Cetera Trust Company left its Boston Scientific share count unchanged in Q2 2026.
Boston Scientific made up 0.02% of Cetera Trust Company's portfolio in Q2 2026, its #242 holding.
Cetera Trust Company first reported a position in Boston Scientific in Q4 2023 and has held it in 11 quarters since.
Cetera Trust Company's Boston Scientific position peaked at $80.1K in Q2 2025.
1,481 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Cetera Trust Company's 13F filing for Q2 2026, filed 13 Aug 2026.